(Q44458191)

English

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM). (English)

1 reference

Europe PubMed Central

3 December 2017

multiple myeloma

1 reference

based on heuristic

inferred from title

Hermann Einsele

2

object named as

Hermann Einsele

1 reference

Europe PubMed Central

3 December 2017

14

object named as

Francis Ayuk

1 reference

Europe PubMed Central

3 December 2017

author name string

Nicolaus Kröger

1

1 reference

Europe PubMed Central

3 December 2017

Daniel Wolff

3

1 reference

Europe PubMed Central

3 December 2017

Jochen Casper

4

1 reference

Europe PubMed Central

3 December 2017

Mathias Freund

5

1 reference

Europe PubMed Central

3 December 2017

Günter Derigs

6

1 reference

Europe PubMed Central

3 December 2017

Hannes Wandt

7

1 reference

Europe PubMed Central

3 December 2017

K Schäfer-Eckart

8

1 reference

Europe PubMed Central

3 December 2017

Georg Wittkowsky

9

1 reference

Europe PubMed Central

3 December 2017

Norbert Schmitz

10

1 reference

Europe PubMed Central

3 December 2017

William Krüger

11

1 reference

Europe PubMed Central

3 December 2017

Tatjana Zabelina

12

1 reference

Europe PubMed Central

3 December 2017

Helmut Renges

13

1 reference

Europe PubMed Central

3 December 2017

Andreas Krüll

15

1 reference

Europe PubMed Central

3 December 2017

Axel Zander

16

1 reference

Europe PubMed Central

3 December 2017

German Study-group Multiple Myeloma (DSMM)

17

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

3 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Bone Marrow Transplantation

1 reference

Europe PubMed Central

3 December 2017

31

1 reference

Europe PubMed Central

3 December 2017

11

1 reference

Europe PubMed Central

3 December 2017

973-979

1 reference

Europe PubMed Central

3 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704049

0 references

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

21 January 2018

Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

21 January 2018

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

21 January 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

21 January 2018

Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

21 January 2018

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

21 January 2018

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-myeloma effect in two cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704049

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704049

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44458191&oldid=1776740043"